PhD, University of California, Berkeley
Imke Janssen, PhD, combines expertise in biostatistics, epidemiology, and behavioral clinical trial methodology to inform her research and to guide and mentor junior researchers to frame their questions and identify appropriate methods to answer them. She has served as the biostatistician on five NIH-funded behavioral clinical trials, primarily targeting underserved populations. She was the Principal Investigator of an innovative study of chronic stress and subclinical cardiovascular disease in women. She has over 85 publications, many of which focus on psychosocial risk for preclinical cardio-metabolic diseases in women. Currently she is leading the Chicago site of the SWAN study, a longitudinal observational study of midlife women now entering its 26th year. This landmark study has shaped our understanding of women’s health through midlife into early old age.